{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:15:45Z","timestamp":1762272945697,"version":"build-2065373602"},"reference-count":31,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173677","ZR2020JQ31"],"award-info":[{"award-number":["82173677","ZR2020JQ31"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science Foundation for Outstanding Young Scholars of Shandong Province","award":["82173677","ZR2020JQ31"],"award-info":[{"award-number":["82173677","ZR2020JQ31"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>PF74 and 11L, as potent modulators of the HIV-1 capsid protein, have been demonstrated to act at both early and late stages in the HIV-1 life cycle. However, their clearance is high in human liver microsomes (HLMs). The main goal of this study was to clarify the metabolism of PF74 and 11L in HLMs, and provide guidance for future structural optimization. To accomplish this, the phase-I metabolites of PF74 and 11L, resulting from in vitro incubation with HLMs, were investigated via ultra-performance liquid chromatography\u2013ultraviolet\u2013high-resolution mass spectrometry (UPLC\u2013UV\u2013HRMS). The results show that 17 phase-I metabolites were putatively annotated for PF74, whereas 16 phase-I metabolites were found for 11L. The main metabolic pathways of PF74 in HLMs were oxidation and demethylation, and the secondary metabolic pathway was hydrolysis; thus, the di-oxidation and demethylation products (M7, M9, M11, and M14) were found to be major metabolites of PF74 in HLMs. In comparison, the main metabolic pathways of 11L in HLMs were oxidation, demethylation, dehydrogenation, and oxidative deamination, with M6\u2032, M11\u2032, M15\u2032, and M16\u2032 as the main metabolites. We suggest that the indole ring and N-methyl group of PF74, and the aniline group, benzene ring R1\u2032, N-methyl, and methoxy group of 11L, were the main metabolic soft spots. Therefore, our research illuminates structural optimization options in seeking improved HIV-1 CA modulators.<\/jats:p>","DOI":"10.3390\/metabo12080752","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T03:15:27Z","timestamp":1660706127000},"page":"752","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Metabolite Identification of HIV-1 Capsid Modulators PF74 and 11L in Human Liver Microsomes"],"prefix":"10.3390","volume":"12","author":[{"given":"Shujing","family":"Xu","sequence":"first","affiliation":[{"name":"Key Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dang","family":"Ding","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1393-4665","authenticated-orcid":false,"given":"Xujie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7302-2214","authenticated-orcid":false,"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan 250012, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41577-018-0085-4","article-title":"Functional cure of HIV: The scale of the challenge","volume":"19","author":"Davenport","year":"2019","journal-title":"Nat. Rev. Immunol."},{"doi-asserted-by":"crossref","unstructured":"Kleinpeter, A.B., and Freed, E.O. (2020). HIV-1 Maturation: Lessons Learned from Inhibitors. Viruses, 12.","key":"ref_2","DOI":"10.3390\/v12090940"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acs.jmedchem.5b00497","article-title":"Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends","volume":"59","author":"Zhan","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2174\/1568026619666190712204603","article-title":"Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication","volume":"19","author":"Maeda","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.4155\/fmc-2020-0084","article-title":"Medicinal chemistry strategies of targeting HIV-1 capsid protein for antiviral treatment","volume":"12","author":"Xu","year":"2020","journal-title":"Future Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4155\/fmc-2022-0008","article-title":"HIV-1 capsid inhibitors: A sword to destroy the virus","volume":"14","author":"Zhang","year":"2022","journal-title":"Future Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"113380","DOI":"10.1016\/j.ejmech.2021.113380","article-title":"An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors","volume":"217","author":"Sun","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/JVI.01406-10","article-title":"Small-Molecule Inhibition of Human Immunodeficiency Virus Type 1 Infection by Virus Capsid Destabilization","volume":"85","author":"Shi","year":"2011","journal-title":"J. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e01741-18","DOI":"10.1128\/JVI.01741-18","article-title":"PF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex","volume":"93","author":"Balasubramaniam","year":"2019","journal-title":"J. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/acs.jmedchem.0c00015","article-title":"Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities","volume":"63","author":"Sun","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1021\/jacs.9b01413","article-title":"Off-Pathway Assembly: A Broad-Spectrum Mechanism of Action for Drugs That Undermine Controlled HIV-1 Viral Capsid Formation","volume":"141","author":"Pak","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"ref_12","first-page":"341","article-title":"Introduction to early in vitro identification of metabolites of new chemical entities in drug discovery and development","volume":"58","author":"Baranczewski","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2478\/acph-2019-0024","article-title":"Metabolic stability and its role in the discovery of new chemical entities","volume":"69","author":"Koczurkiewicz","year":"2019","journal-title":"Acta Pharm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/jm8008663","article-title":"Metabolic Soft Spot Identification and Compound Optimization in Early Discovery Phases Using MetaSite and LC-MS\/MS Validation","volume":"52","author":"Trunzer","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"114102","DOI":"10.1016\/j.jpba.2021.114102","article-title":"NOX2 inhibitor GSK2795039 metabolite identification towards drug optimization","volume":"201","author":"Padilha","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"doi-asserted-by":"crossref","unstructured":"Lee, K., Lee, J.-Y., Lee, K., Jung, C.-R., Kim, M.J., Kim, J.A., Yoo, D.G., Shin, E.J., and Oh, S.J. (2021). Metabolite Profiling and Characterization of LW6, a Novel HIF-1\u03b1 Inhibitor, as an Antitumor Drug Candidate in Mice. Molecules, 26.","key":"ref_16","DOI":"10.3390\/molecules26071951"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0021-9673(03)00303-0","article-title":"Liquid chromatography with ultraviolet absorbance-mass spectrometric detection and with nuclear magnetic resonance spectroscopy: A powerful combination for the on-line structural investigation of plant metabolites","volume":"1000","author":"Wolfender","year":"2003","journal-title":"J. Chromatogr. A"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11095-006-9162-7","article-title":"Analytical Tools and Approaches for Metabolite Identification in Early Drug Discovery","volume":"24","author":"Chen","year":"2007","journal-title":"Pharm. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1055\/s-0042-101763","article-title":"Combined LC\/UV\/MS and NMR Strategies for the Dereplication of Marine Natural Products","volume":"82","author":"Reyes","year":"2016","journal-title":"Planta. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/dta.1655","article-title":"Identification and characterization by LC-UV-MS\/MS of melanotan II skin-tanning products sold illegally on the Internet","volume":"7","author":"Breindahl","year":"2015","journal-title":"Drug Test. Anal."},{"doi-asserted-by":"crossref","unstructured":"Liang, Y., Zhao, W., Wang, C., Wang, Z., Wang, Z., and Zhang, J. (2018). A Comprehensive Screening and Identification of Genistin Metabolites in Rats Based on Multiple Metabolite Templates Combined with UHPLC-HRMS Analysis. Molecules, 23.","key":"ref_21","DOI":"10.3390\/molecules23081862"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e4623","DOI":"10.1002\/jms.4623","article-title":"Identification of suberosin metabolites in human liver microsomes by high-performance liquid chromatography combined with high-resolution quadrupole\u2013orbitrap mass spectrometer","volume":"56","author":"Paudel","year":"2021","journal-title":"Biol. Mass Spectrom."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/rcm.6710","article-title":"Characterization of metabolites of GLS4 in humans using ultrahigh-performance liquid chromatography\/quadrupole time-of-flight mass spectrometry","volume":"27","author":"Zhou","year":"2013","journal-title":"Rapid Commun. Mass Spectrom."},{"doi-asserted-by":"crossref","unstructured":"Montesano, C., Vincenti, F., Fanti, F., Marti, M., Bilel, S., Togna, A., Gregori, A., Di Rosa, F., and Sergi, M. (2021). Untargeted Metabolic Profiling of 4-Fluoro-Furanylfentanyl and Isobutyrylfentanyl in Mouse Hepatocytes and Urine by Means of LC-HRMS. Metabolites, 11.","key":"ref_24","DOI":"10.3390\/metabo11020097"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.apsb.2020.07.016","article-title":"Novel PF74-like small molecules targeting the HIV-1 capsid protein: Balance of potency and metabolic stability","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"113903","DOI":"10.1016\/j.ejmech.2021.113903","article-title":"Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability","volume":"227","author":"Xu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"doi-asserted-by":"crossref","unstructured":"Sahani, R., Diana-Rivero, R., Vernekar, S., Wang, L., Du, H., Zhang, H., Castaner, A., Casey, M., Kirby, K., and Tedbury, P. (2021). Design, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74. Viruses, 13.","key":"ref_27","DOI":"10.3390\/v13030479"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1021\/cr4002879","article-title":"Fluorine in pharmaceutical industry: Fluorine-containing drugs introduced to the market in the last decade (2001\u20132011)","volume":"114","author":"Wang","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1039\/D1MD00292A","article-title":"Potency and metabolic stability: A molecular hybrid case in the design of novel PF74-like small molecules targeting HIV-1 capsid protein","volume":"12","author":"Sahani","year":"2021","journal-title":"RSC Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1126\/science.abb4808","article-title":"Structural and mechanistic bases for a potent HIV-1 capsid inhibitor","volume":"370","author":"Bester","year":"2020","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41586-020-2443-1","article-title":"Clinical targeting of HIV capsid protein with a long-acting small molecule","volume":"584","author":"Link","year":"2020","journal-title":"Nature"}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/12\/8\/752\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:10:33Z","timestamp":1760141433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/12\/8\/752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["metabo12080752"],"URL":"https:\/\/doi.org\/10.3390\/metabo12080752","relation":{},"ISSN":["2218-1989"],"issn-type":[{"type":"electronic","value":"2218-1989"}],"subject":[],"published":{"date-parts":[[2022,8,16]]}}}